N※N

Why the Smartest Investors Are Buying Philip Morris International Stock and Not Altria | The Motley Fool

Why the Smartest Investors Are Buying Philip Morris Stock Right Now

In the ever-evolving landscape of global investments, few companies have managed to reinvent themselves as dramatically as Philip Morris International (NYSE: PM). Once synonymous with traditional tobacco products, the company has pivoted toward a smoke-free future, and this transformation is catching the eye of savvy investors. As we delve into the reasons behind this surge in interest, it's clear that Philip Morris isn't just surviving in a declining industry—it's thriving by leading the charge in innovation and sustainability. This article explores the key factors driving smart money into PM stock, from its robust financials and dividend appeal to its strategic shift away from combustible cigarettes.

At the heart of Philip Morris's appeal is its ambitious goal to become a predominantly smoke-free company. The tobacco giant has invested billions in research and development to create alternatives to traditional cigarettes, with its heated tobacco product, IQOS, leading the pack. IQOS, which heats tobacco rather than burning it, reduces harmful chemicals compared to smoking and has gained massive traction worldwide. As of mid-2025, IQOS boasts over 30 million users across more than 80 markets, representing a significant portion of the company's revenue. This isn't just a side project; it's the core of Philip Morris's strategy. The company aims for smoke-free products to account for two-thirds of its net revenue by 2030, up from about 40% currently. This forward-thinking approach positions PM not as a relic of the past but as a pioneer in harm-reduction technology, appealing to health-conscious consumers and regulators alike.

Investors are particularly drawn to the financial stability that underpins this transformation. Philip Morris has consistently delivered strong earnings growth, even amid regulatory pressures on traditional tobacco. In its latest quarterly report, the company reported a 10% increase in adjusted diluted earnings per share, driven largely by the success of its smoke-free portfolio. Revenue from heated tobacco units and oral nicotine products surged by 15%, offsetting any declines in cigarette volumes. This resilience is crucial in an industry facing headwinds like increasing taxes, smoking bans, and public health campaigns. Moreover, PM's operating margins remain impressive, hovering around 40%, thanks to efficient cost management and pricing power in premium markets.

One of the most compelling reasons smart investors are piling into Philip Morris is its status as a dividend aristocrat. With a forward dividend yield of approximately 4.5%, PM offers a reliable income stream that's hard to ignore in a low-interest-rate environment. The company has raised its dividend for 15 consecutive years, demonstrating a commitment to shareholder returns. This payout is well-supported by free cash flow, which exceeded $10 billion last year, providing ample room for both dividends and reinvestments in growth initiatives. For income-focused investors, especially those in retirement or seeking passive income, PM represents a blue-chip stock with a proven track record of weathering economic storms. Unlike high-growth tech stocks that can be volatile, Philip Morris provides stability, making it a staple in diversified portfolios.

Beyond dividends, the company's global footprint adds another layer of attractiveness. Philip Morris operates in over 180 countries, giving it exposure to emerging markets where tobacco consumption patterns are shifting but demand for alternatives is rising. In regions like Asia and Europe, IQOS has seen explosive growth, with Japan alone accounting for millions of users. This international diversification mitigates risks from any single market's regulations. For instance, while the U.S. has stringent FDA oversight, Philip Morris's focus on international operations shields it from domestic turbulence. The company's acquisition of Swedish Match in 2022 further bolstered its position in oral nicotine products like Zyn, which has become a sensation in the nicotine pouch category. Zyn's sales have doubled in key markets, tapping into a younger demographic seeking discreet, smoke-free options.

Smart investors also appreciate Philip Morris's commitment to environmental, social, and governance (ESG) principles, which is increasingly important in today's investment world. The company has set aggressive targets to reduce its carbon footprint, aiming for carbon neutrality in its direct operations by 2030. Initiatives include sustainable farming practices for tobacco leaves and reducing plastic waste in packaging. On the social front, PM's harm-reduction efforts align with global health goals, potentially earning it favor from ESG funds that might otherwise shun tobacco stocks. While some critics argue that tobacco companies can't truly be "sustainable," Philip Morris's transparency reports and third-party verifications are winning over skeptics. This ESG pivot could open doors to more institutional investment, as funds with trillions in assets under management prioritize responsible investing.

Of course, no investment is without risks, and smart buyers are well aware of them. Regulatory hurdles remain a significant threat; governments worldwide are tightening rules on nicotine products, including potential flavor bans or advertising restrictions that could impact IQOS and Zyn. Litigation is another perennial concern, with ongoing lawsuits related to health claims from past tobacco use. Currency fluctuations, given PM's international exposure, can also affect earnings when reported in U.S. dollars. Additionally, the shift to smoke-free products isn't guaranteed to succeed everywhere—cultural preferences and competition from vaping giants like Juul or even cannabis alternatives could erode market share.

Despite these challenges, the bull case for Philip Morris is compelling. Analysts project earnings growth of 8-10% annually over the next five years, supported by expanding margins and new product launches. The stock's price-to-earnings ratio, around 18, is reasonable compared to peers in consumer goods, suggesting it's not overvalued. Value investors like Warren Buffett's Berkshire Hathaway have historically favored similar defensive stocks with strong brands and cash flows, and while Buffett himself avoids tobacco, the parallels are evident in PM's moat-like qualities.

Looking ahead, Philip Morris is exploring even more innovative frontiers, such as wellness and pharmaceutical applications derived from its nicotine research. Partnerships with tech firms for smart devices and data analytics could further enhance user engagement and retention. Imagine a future where PM's products not only reduce harm but also integrate with health apps to monitor usage and promote cessation—it's a bold vision that could redefine the company.

In conclusion, the smartest investors are buying Philip Morris because it embodies a rare blend of defensive strength, growth potential, and adaptability. In a market obsessed with disruptive tech, PM offers a contrarian play: a legacy company that's aggressively modernizing while rewarding shareholders handsomely. Whether you're a dividend hunter, a growth seeker, or an ESG advocate, there's something in Philip Morris's story that resonates. As the world moves toward a smoke-free era, this tobacco titan is positioning itself not just to survive, but to lead. If history is any guide, betting on such transformations has paid off handsomely for those with the foresight to act. (Word count: 1,028)

Read the Full The Motley Fool Article at:
[ https://www.fool.com/investing/2025/07/18/why-the-smartest-investors-are-buying-philip-morri/ ]